PERRIGO Co plc — Director's Dealing 2023

Mar 7, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PERRIGO Co plc (PRGO)
CIK: 0001585364
Period of Report: 2023-03-03

Reporting Person: Quinn Grainne (EVP, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-03	Ordinary Shares	A	5419	$38.75	Acquired	14537	Direct
2023-03-03	Ordinary Shares	F	2818	$38.75	Disposed	11719	Direct
2023-03-03	Ordinary Shares	M	1052	$38.75	Acquired	12771	Direct
2023-03-03	Ordinary Shares	F	548	$38.75	Disposed	12223	Direct
2023-03-03	Ordinary Shares	M	1584	$38.75	Acquired	13807	Direct
2023-03-03	Ordinary Shares	F	824	$38.75	Disposed	12983	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-03	Restricted Stock Units	$	M	1052	Disposed		Ordinary Shares (1052.0)	Direct
2023-03-03	Restricted Stock Units	$	M	1584	Disposed		Ordinary Shares (1584.0)	Direct

Footnotes

F1: Vesting of performance-based restricted stock units granted on March 5, 2020.

F2: Vesting of service-based restricted stock units granted on March 5, 2020.

F3: Vesting of service-based restricted stock units granted on March 5, 2021.

F4: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F5: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2021.

F6: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 5 March 2022.